Přejít k obsahu
Merck

Depot fluphenazine: risk/benefit ratio.

The Journal of clinical psychiatry (1984-05-01)
W M Glazer
ANOTACE

The risks and benefits associated with depot fluphenazine are reassessed by a review and critique of the literature, with an emphasis on controlled studies comparing depot to oral preparations. Specific gaps in our knowledge are noted and recommendations are made for future research.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Fluphenazine enantate, European Pharmacopoeia (EP) Reference Standard